Susan M. Harless, Ph.D. - Publications
Affiliations: | 2000-2004 | Immunology Graduate Group | University of Pennsylvania Perelman School of Medicine |
2004-2006 | Immunology | Max Planck Institute, Freiburg | |
2006-2012 | Microbiology and Immunology | Duke Medical School, Durham, NC, United States | |
2012-2017 | Immunology | Steifel/GSK |
Area:
Skin ImmunologyYear | Citation | Score | |||
---|---|---|---|---|---|
2002 | Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. Journal of Immunology (Baltimore, Md. : 1950). 168: 5993-6. PMID 12055205 DOI: 10.4049/Jimmunol.168.12.5993 | 0.637 | |||
2001 | Harless SM, Lentz VM, Sah AP, Hsu BL, Clise-Dwyer K, Hilbert DM, Hayes CE, Cancro MP. Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Current Biology : Cb. 11: 1986-9. PMID 11747827 DOI: 10.1016/S0960-9822(01)00598-X | 0.382 | |||
2001 | Yan M, Brady JR, Chan B, Lee WP, Hsu B, Harless S, Cancro M, Grewal IS, Dixit VM. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency Current Biology. 11: 1547-1552. PMID 11591325 DOI: 10.1016/S0960-9822(01)00481-X | 0.696 | |||
Show low-probability matches. |